IDR Data
CMS PUF data · 2023 Q1–2025 Q4

Federal IDR outcomes: Vascular surgery

In 2025 Q1–Q4, the provider or facility offer prevailed in 86.4% of 8,438 determined Federal IDR dispute line items for vascular surgery. The median prevailing offer was 46.42x the QPA (25th–75th percentile 13.57x–92.87x; n = 7,945). The median time to a decision was 29 business days (n = 8,438).

Specialty group built from the CMS free-text specialty field; see the grouping rules.

Determined line items

8,438

2025 Q1–Q4 · 4 split decisions excluded

Provider win rate

86.4%

n = 8,438 · 2025 Q1–Q4

Median payment vs QPA

46.42x †

middle half 13.57x–92.87x · n = 7,945 · 2025 Q1–Q4

Median days to decision

29

business days, from dispute initiation · n = 8,438 · 2025 Q1–Q4

Dollar amounts are not shown for specialty groups: the CMS QPA and Offers file, the only source of dollar figures, has no specialty field. See methodology.

By period

PeriodLine itemsWin %Median ×QPA25th–75thRatio nMedian days
2025 Q1–Q48,43886.4%46.42x †13.57x–92.87x7,94529
2024 Q1–Q41,63287.3%28.67x †6.80x–58.75x1,42250
2023 Q1–Q423385.8%23.19x †6.80x–42.09x22472
2023 Q1–2025 Q410,30386.5%43.06x †11.69x–89.82x9,591not pooled

Line items = determined dispute line items (n). Win rate excludes split decisions and includes default decisions. Ratio n = line items reporting a payment-to-QPA ratio. Days are business days as reported by CMS (2023–2024: from IDR entity assignment; 2025: from initiation) and are never pooled.

By state

State (place of service)Line itemsWin %Median ×QPARatio nMedian days
New Jersey3,49787.7%58.42x †3,22629
New York2,04978.6%34.63x †2,01631
California1,92987.9%64.95x †1,92425
Wisconsin41998.3%16.80x28340
Nevada33992.0%64.36x †33925
Arizona9595.8%57.06x †9428
Pennsylvania6998.6%–2327

2025 Q1–Q4 · rows with n ≥ 30 determined line items · sorted by n.

Most disputed CPT codes

CPT codeLine itemsWin %Median ×QPARatio nMedian days
99232 Subsequent hospital care with moderate levelof medical decision making, if using1,08584.1%45.83x †1,07127
36475 Destruction of first incompetent vein of arm or leg using radiofrequency and ima84483.3%68.34x †83129
99233 Subsequent hospital care with moderate levelof medical decision making, if using75779.9%33.57x †75146
93970 Ultrasound study of arm or leg veins with compression and maneuvers43287.3%86.41x †43125
22558 Fusion of lower spine bone through abdomen with partial removal of disc36587.4%46.36x †31726
99231 Subsequent hospital care with straightforward or low level of medical decision m26192.3%99.05x †26128
22853 Insertion of cage or mesh device to spine bone and disc space during spine fusio23488.9%429.18x †18131
36476 Destruction of subsequent incompetent veins of arm or leg using radiofrequency a21983.1%187.10x †21428
99497 Advance care planning, first 30 minutes19477.3%34.95x †18935
36466 Injection of chemical agent into multiple incompetent veins of same leg using ul18783.4%123.92x †18633
22585 Fusion of spine bones through front of body with partial removal of disc, each a18593.0%92.17x †16328
93971 Ultrasound study of one arm or leg veins with compression and maneuvers18483.2%95.46x †18120.5
99291 Critical care, first 30-74 minutes15986.2%19.59x15727
99284 Emergency department visit with moderate level of medical decision making14484.0%24.49x †13529
99223 Initial hospital care with moderate level of medical decision making, if using t12988.4%16.58x12832
76937 Ultrasonic guidance for blood vessel access11984.0%249.05x †11925
35221 Repair of blood vessel of abdomen11292.9%16.20x9234
99255 Hospital consultation with high level of medical decision making, if using time,10771.0%29.77x †10431
37799 Other procedure on blood vessel10586.7%3.17x5631
36465 Injection of chemical agent into single incompetent vein of leg using ultrasound10184.2%88.86x †10025
64483 Injection of anesthetic and/or steroid drug into sacral spine nerve root using i9999.0%17.12x7138
22845 Placement of stabilizing device to front, 2-3 spine bone segments9389.2%166.72x †7533
99222 Initial hospital care with straightforward or low-level medical decision making,7892.3%33.54x †7828.5
22857 Insertion of artificial disc between bones of lower spine, single space7288.9%67.91x †6725
62321 Injection of substance into middle or upper spine canal using imaging guidance71100.0%12.77x5542

2025 Q1–Q4 · rows with n ≥ 30 determined line items · sorted by n.

FAQ

What is the Federal IDR provider win rate for vascular surgery?

In 2025 Q1–Q4, the provider or facility offer was selected in 86.4% of 8,438 determined dispute line items for vascular surgery. Split decisions are excluded from the denominator and default decisions are included. Withdrawn, settled and ineligible disputes are not in the CMS data.

How do Federal IDR payments compare with the QPA for vascular surgery?

In 2025 Q1–Q4, the median prevailing offer was 46.42x the qualifying payment amount (QPA), with a 25th to 75th percentile range of 13.57x to 92.87x (n = 7,945 line items). This uses the CMS field Prevailing Party Offer as % of QPA, where 1.00x equals the QPA.

How long do Federal IDR decisions take for vascular surgery?

In 2025 Q1–Q4, the median was 29 business days (n = 8,438 line items), using the CMS field Length of Time to Make Determination (from dispute initiation).

How to Utilize IDR